Abubakar M, Nama L, Ansari MA, Ansari MM, Bhardwaj S, Daksh R, Syamala KLV, Jamadade MS, Chhabra V, Kumar D, Kumar N (2024) GLP-1/GIP Agonist as an Intriguing and Ultimate Remedy for Combating Alzheimers Disease through its Supporting DPP4 Inhibitors: A Review
Enhanced Metabolic Flexibility : Many patients report increased energy, better glucose control, and fewer cravingsoften with better adherence to exercise and sleep routines
Key variants like GIPR rs1800437 and FTO rs9939609, and MC4R rs17782313 help PlexusDx tailor your compounded medication protocol to your individual biology
Join the KidneyCARE Study and make a difference
Consume 1-2 servings per day, ideally with food